Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-25 @ 4:01 PM
Study NCT ID:
NCT02741557
Status:
COMPLETED
Last Update Posted:
2019-07-15
First Post:
2016-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-14
First Submit QC Date:
None
Study First Post Date:
2016-04-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-11
Last Update Post Date:
2019-07-15
Last Update Post Date Type:
ACTUAL